{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:20:10Z","timestamp":1772767210003,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T00:00:00Z","timestamp":1482192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1245\/s10434-016-5729-7","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T10:15:38Z","timestamp":1482228938000},"page":"1336-1342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment Preferences for Routine Lymphadenectomy Versus No Lymphadenectomy in Early-Stage Endometrial Cancer"],"prefix":"10.1245","volume":"24","author":[{"given":"Jung-Yun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyunghoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Shin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Ji","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunghoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Wun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Weon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"key":"5729_CR1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3802\/jgo.2014.25.3.174","volume":"25","author":"JY Lee","year":"2014","unstructured":"Lee JY, Kim EY, Jung KW, et al. Trends in gynecologic cancer mortality in East Asian regions. J Gynecol Oncol. 2014;25:174\u201382.","journal-title":"J Gynecol Oncol."},{"key":"5729_CR2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3802\/jgo.2013.24.4.298","volume":"24","author":"MC Lim","year":"2013","unstructured":"Lim MC, Moon EK, Shin A, et al. Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999\u20132010. J Gynecol Oncol. 2013;24:298\u2013302.","journal-title":"J Gynecol Oncol."},{"key":"5729_CR3","doi-asserted-by":"crossref","unstructured":"Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy versus no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707\u201316.","DOI":"10.1093\/jnci\/djn397"},{"key":"5729_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(09)60678-4","volume":"373","author":"H Kitchener","year":"2009","unstructured":"Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125\u201336.","journal-title":"Lancet."},{"key":"5729_CR5","doi-asserted-by":"crossref","unstructured":"Frost JA, Webster KE, Bryant A, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 2015;9:CD007585.","DOI":"10.1002\/14651858.CD007585.pub3"},{"key":"5729_CR6","unstructured":"National Comprehensive Cancer Center (NCCN). NCCN clinical practice guidelines in oncology: uterine neoplasms. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uterine.pdf . Accessed 4 June 2015."},{"key":"5729_CR7","doi-asserted-by":"crossref","unstructured":"Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO Consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016;27:16\u201341.","DOI":"10.1093\/annonc\/mdv484"},{"key":"5729_CR8","unstructured":"Korean Society of Gynecologic Cancer. Pratice guideline for gynecologic cancer. version 3.0. http:\/\/www.sgo.or.kr\/ . Accessed 5 May 2016."},{"key":"5729_CR9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3802\/jgo.2015.26.4.277","volume":"26","author":"JY Lee","year":"2015","unstructured":"Lee JY, Kim K, Lee TS, et al. Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group. J Gynecol Oncol. 2015;26:277\u201383.","journal-title":"J Gynecol Oncol."},{"key":"5729_CR10","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/cncr.25842","volume":"117","author":"ED Kennedy","year":"2011","unstructured":"Kennedy ED, Schmocker S, Victor C, et al. Do patients consider preoperative chemoradiation for primary rectal cancer worthwhile? Cancer. 2011;117:2853\u201362.","journal-title":"Cancer."},{"key":"5729_CR11","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1200\/JCO.2006.07.4955","volume":"25","author":"PF Stalmeier","year":"2007","unstructured":"Stalmeier PF, van Tol-Geerdink JJ, van Lin EN, et al. Doctors\u2019 and patients\u2019 preferences for participation and treatment in curative prostate cancer radiotherapy. J Clin Oncol. 2007;25:3096\u2013100.","journal-title":"J Clin Oncol."},{"key":"5729_CR12","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1200\/JCO.2006.05.9592","volume":"24","author":"JJ Tol-Geerdink van","year":"2006","unstructured":"van Tol-Geerdink JJ, Stalmeier PF, van Lin EN, et al. Do patients with localized prostate cancer treatment really want more aggressive treatment? J Clin Oncol. 2006;24:4581\u20136.","journal-title":"J Clin Oncol."},{"key":"5729_CR13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bjc.6603954","volume":"97","author":"AH Pieterse","year":"2007","unstructured":"Pieterse AH, Stiggelbout AM, Baas-Thijssen MC, van de Velde CJ, Marijnen CA. Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients\u2019 and oncologists\u2019 preferences. Br J Cancer. 2007;97:717\u201324.","journal-title":"Br J Cancer."},{"key":"5729_CR14","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1093\/annonc\/mdt195","volume":"24","author":"H Wouters","year":"2013","unstructured":"Wouters H, Maatman GA, Van Dijk L, et al. Trade-off preferences regarding adjuvant endocrine therapy among women with estrogen receptor\u2013positive breast cancer. Ann Oncol. 2013;24:2324\u20139.","journal-title":"Ann Oncol."},{"key":"5729_CR15","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/annonc\/mdr559","volume":"23","author":"P Blinman","year":"2012","unstructured":"Blinman P, King M, Norman R, Viney R, Stockler MR. Preferences for cancer treatments: an overview of methods and applications in oncology. Ann Oncol. 2012;23:1104\u201310.","journal-title":"Ann Oncol."},{"key":"5729_CR16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1200\/JCO.2001.19.1.220","volume":"19","author":"AM Stiggelbout","year":"2001","unstructured":"Stiggelbout AM, de Haes JC. Patient preference for cancer therapy: an overview of measurement approaches. J Clin Oncol. 2001;19:220\u201330.","journal-title":"J Clin Oncol."},{"key":"5729_CR17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ygyno.2014.09.020","volume":"135","author":"JY Lee","year":"2014","unstructured":"Lee JY, Cohn DE, Kim Y, et al. The cost-effectiveness of selective lymphadenectomy based on a preoperative prediction model in patients with endometrial cancer: insights from the US and Korean healthcare systems. Gynecol Oncol. 2014;135:518\u201324.","journal-title":"Gynecol Oncol."},{"key":"5729_CR18","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1002\/cncr.25068","volume":"116","author":"AL Cheville","year":"2010","unstructured":"Cheville AL, Almoza M, Courmier JN, Basford JR. A prospective cohort study defining utilities using time trade-offs and the Euroqol-5D to assess the impact of cancer-related lymphedema. Cancer. 2010;116:3722\u201331.","journal-title":"Cancer."},{"key":"5729_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2007.08.072","volume":"108","author":"JA Lachance","year":"2008","unstructured":"Lachance JA, Stukenborg GJ, Schneider BF, Rice LW, Jazaeri AA. A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma. Gynecol Oncol. 2008;108:77\u201383.","journal-title":"Gynecol Oncol."},{"key":"5729_CR20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2012.06.035","volume":"127","author":"SC Dowdy","year":"2012","unstructured":"Dowdy SC, Borah BJ, Bakkum-Gamez JN, et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol. 2012;127:5\u201310.","journal-title":"Gynecol Oncol."},{"key":"5729_CR21","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1245\/s10434-015-4504-5","volume":"22","author":"A Papadia","year":"2015","unstructured":"Papadia A, Bellati F, Ditto A, et al. Surgical treatment of recurrent endometrial cancer: time for a paradigm shift. Ann Surg Oncol. 2015;22:4204\u201310.","journal-title":"Ann Surg Oncol."},{"key":"5729_CR22","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1007\/s00268-015-3148-8","volume":"39","author":"EW Bekker-Grob de","year":"2015","unstructured":"de Bekker-Grob EW, Niers EJ, van Lanschot JJ, Steyerberg EW, Wijnhoven BP. Patients\u2019 preferences for surgical management of esophageal cancer: a discrete choice experiment. World J Surg. 2015;39:2492\u20139.","journal-title":"World J Surg."},{"key":"5729_CR23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/bjc.2014.322","volume":"111","author":"M Kunneman","year":"2014","unstructured":"Kunneman M, Pieterse AH, Stiggelbout AM, et al. Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians. Br J Cancer. 2014;111:674\u20139.","journal-title":"Br J Cancer."},{"key":"5729_CR24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2013.01.005","volume":"129","author":"S Kang","year":"2013","unstructured":"Kang S, Todo Y, Odagiri T, et al. A low-risk group for lymph node metastasis is accurately identified by Korean Gynecologic Oncology Group criteria in two Japanese cohorts with endometrial cancer. Gynecol Oncol. 2013;129:33\u20137.","journal-title":"Gynecol Oncol."},{"key":"5729_CR25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2012.02.021","volume":"125","author":"JN Barlin","year":"2012","unstructured":"Barlin JN, Khoury-Collado F, Kim CH, et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol. 2012;125:531\u20135.","journal-title":"Gynecol Oncol."},{"key":"5729_CR26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2016.03.079","volume":"61","author":"M Koskas","year":"2016","unstructured":"Koskas M, Fournier M, Vanderstraeten A, et al. Evaluation of models to predict lymph node metastasis in endometrial cancer: a multicentre study. Eur J Cancer. 2016;61:52\u201360.","journal-title":"Eur J Cancer."},{"key":"5729_CR27","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","volume":"23","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703\u201320.","journal-title":"J Clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5729-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-016-5729-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5729-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:22:23Z","timestamp":1498357343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-016-5729-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["5729"],"URL":"https:\/\/doi.org\/10.1245\/s10434-016-5729-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,20]]}}}